HOWL — Werewolf Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1785530 ·
Last close
$0.91
Market Cap
$44.23M
52W High
$1.94
52W Low
$0.27
ADV30
834,708
Next earnings
2026-10-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 21,000,000 | — | 7,158,000 | 3,670,000 | 24,155,000 | 21,987,000 | 7,863,000 |
| Mar 2026 | 0 | — | -13,271,000 | -13,532,000 | 58,022,000 | 46,450,000 | 45,820,000 |
| Dec 2025 | 0 | — | -9,418,000 | -8,381,000 | 69,396,000 | 57,050,000 | 44,591,000 |
| Sep 2025 | 0 | — | -15,726,000 | -16,370,000 | 79,627,000 | 65,711,000 | 50,013,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-30,148,000
Investing CF
$0
Financing CF
$6,028,000
CapEx
$-123,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.76
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-485,272,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-30,060,000
Pretax Income TTM
$-34,613,000
Interest Exp TTM
$4,553,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$21,000,000
EBITDA
$-21,921,000
Free Cash Flow
$-12,233,750
Enterprise Value
$25,737,282
Total Cash
$21,987,000
Total Debt
$0
Shares Out
48,599,066
Trailing EPS
$-0.73
Book Value
$0.34
ROE
-119.9%
ROA
-27.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -60,677,000 | -60,822,000 | 69,396,000 | 44,591,000 | 24,805,000 | -60,292,000 |
| Dec 2024 | 1,885,000 | -73,594,000 | -70,515,000 | 126,929,000 | 53,539,000 | 73,390,000 | -56,188,000 |
| Dec 2023 | 19,943,000 | -40,503,000 | -37,368,000 | 174,833,000 | 63,459,000 | 111,374,000 | -32,612,000 |
| Dec 2022 | 16,401,000 | -56,056,000 | -53,810,000 | 160,245,000 | 37,908,000 | 122,337,000 | -40,596,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$2,544,000
NetIncome TTM
$-56,265,000
OpCashFlow TTM
—
Assets (Latest)
$58,022,000
Forward EPS
$-0.59
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $0.50 · spot: $0.98 · call volume: 32 · put volume: 0
Expected Move to 2026-10-16:
±$0.23
(22.97%) —
implied range
$0.75 –
$1.20
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PRRUF | IMMUTEP Ltd | $44.21M | $0.03 | — |
| GRCE | Grace Therapeutics, Inc. | $42.91M | $2.04 | — |
| NSRX | Nasus Pharma Ltd | $42.52M | $3.63 | — |
| SCYX | SCYNEXIS INC | $41.99M | $4.22 | — |
| MTNB | Matinas BioPharma Holdings, Inc. | $41.58M | $2.83 | — |
News headlines (Yahoo Finance, 1h cache)
New Strong Buy Stocks for October 9th
2026-10-09 09:46 · Yahoo
1 Penny Stock That Could Howl Its Way to the Top After a $150 Million Funding Boost
2026-08-26 15:47 · Yahoo
Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News
2026-08-21 17:51 · Yahoo
Werewolf Therapeutics shares surge 120% after Ambros merger and $150 million financing
2026-08-21 13:26 · Yahoo
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement
2026-08-21 12:00 · Yahoo
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
2026-07-31 11:00 · Yahoo
Here's Why We're A Bit Worried About Werewolf Therapeutics' (NASDAQ:HOWL) Cash Burn Situation
2026-05-14 11:23 · Yahoo
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
2026-05-07 20:05 · Yahoo
HALO Expands ENHANZE Collaboration & Licensing Deal With ARGX
2026-10-07 13:58 · Yahoo
Sector Update: Healthcare Stocks Advance in Afternoon Trading
2026-08-21 17:43 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.